Submission Deadline: June 15, 2025
Notification of Acceptance: June 30, 2025
Presenting Author’s registration deadline: July 20, 2025
Notification of Acceptance: June 30, 2025
Presenting Author’s registration deadline: July 20, 2025
Main Topics
- AI as a game changer in STI & HIV Clinics
- AI boosting STI & HIV research
- Gender identity, inclusion, diversity
- Genital cosmetology
- Less frequent venereal diseases: not to be ignored!
- New trends in STIs & HIV
- Psoriasis, hidradenitis suppurativa and other immune-mediated inflammatory diseases on the anogenital area
- Special populations in STIs & HIV
- STIs severely impacting general health
Submission Guidelines and General Policies
All abstracts, regardless of whether they are submitted for oral, or poster presentations will be reviewed to appraise the quality of the work presented. The Scientific Committee will evaluate all abstracts submitted for presentation. The authors will be notified regarding acceptance of their abstracts and the type of presentation by June 30th, 2025.
Language: All abstracts should be submitted and presented in English, which is the official language of the Congress, using accurate grammar and spelling suitable for publication. If in doubt, please arrange for the review of your abstract by a native English speaker or by a university scientific publications office (or other similar facility) before submission, as it will be reproduced exactly as submitted. No proofreading will be done.
Corresponding Author: The abstract submission form should be completed by the Corresponding Author, who will be responsible for all future communications regarding the submitted abstract.
Account: Each submitter (Corresponding Author) is required to create a user account indicating an account email address and a password. The email and password indicated will be used for all online forms of the Congress (i.e. Registration Form).
Abstract Title:
- The abstract title should be brief and reflect the content of the abstract.
- The abstract title should be typed in lowercase letters, except for abbreviations and study names. Please be careful that your title might be truncated if you copy and paste it into the field.
- Do not refer to study results or conclusions in the title of the abstract. The title should objectively describe the study.
Topic: Authors are invited to select the topic that better fits the scope of their abstract among the Congress topics; the final assignment will be made by the Scientific Committee.
Authors:
- Names of authors should be written in upper/ lower cases in the following way: {Full name with the first letter in upper case (e.g. John)} {Surname (Family Name) with the first letter in upper case (e.g. Smith)}
- Please enter the first name in full, followed by the surname (Family Name), for each author, without abbreviations (e.g. John Smith, and NOT J. Smith). The names, e-mail addresses and full affiliations of all authors should be entered.
- Each abstract can have a maximum of 25 authors.
Text Body:
- The text (excluding title, authors, and affiliations) should not exceed 350 words.
- Organize the abstract according to four sections, identified by the following headers:
- Background
- Material and Methods
- Results
- Conclusion
- Do not include illustrations with the abstract.
- Place abbreviations in parentheses immediately after the first mention of a term or phrase; the abbreviation can then be used throughout the abstract.
- Table(s), Figures, and photographs may be included.
- Describe the objectives and results of the research in the abstract so that the Abstract Evaluation Committee can evaluate the quality, originality, and completeness of the abstract. Abstracts will be judged solely based on the data in the submitted abstract.
Registration fees should accompany all abstract submissions. Presenters are expected to attend the 38th IUSTI Europe Congress and are required to pay the registration fee and all expenses involved.
The presentation of the abstract and its publication in the Final Program and the Abstract Book is conditional upon payment of the registration fee by the presenting author. Please note that if we do not receive the requested payment, the abstract, much to our regret, will not be included either in the Abstract Book or in the Final Program of the Congress.
Notification of Acceptance
- All abstracts received will be evaluated by members of the Scientific Committee.
- Notification of acceptance or rejection of abstracts will be sent to the corresponding authors of each abstract by June 30th, 2025.
- Each abstract’s corresponding author will be notified of the evaluation procedure’s results. The corresponding author receives all information concerning the abstract and is responsible for informing all other co-authors of the status of the abstract.
- Presenting authors' registration deadline: July 20th, 2025. Please note that the online registration portal will be live on October 31st, 2024.
- All abstract presenters will be asked to reconfirm their attendance after receiving the notification. If you do not re-confirm your abstract presentation, register and pay the registration fee before the given deadline, your abstract(s) will be retracted from the Program.
- Accepted abstracts will be considered for Oral or Poster presentation. Please note that the Scientific Committee reserves the right to request the change of your abstract’s presentation type and/or session, according to the Program's specifications and needs.
For further information regarding abstract submission and presentation, please contact the Congress Organizing Secretariat at info@iustieurope2025.org.